The estimated Net Worth of Plus, Llc I9 is at least $5.18 Milión dollars as of 5 August 2022. Plus I9 owns over 112,561 units of Rafael Inc stock worth over $4,967,741 and over the last 2 years Plus sold RFL stock worth over $211,615.
Sign up
Plus I9 RFL stock SEC Form 4 insiders trading
Plus has made over 1 trades of the Rafael Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently Plus sold 112,561 units of RFL stock worth $211,615 on 5 August 2022.
The largest trade Plus's ever made was selling 112,561 units of Rafael Inc stock on 5 August 2022 worth over $211,615. On average, Plus trades about 112,561 units every 0 days since 2022. As of 5 August 2022 Plus still owns at least 3,225,806 units of Rafael Inc stock.
You can see the complete history of Plus I9 stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Plus I9's mailing address?
Plus's mailing address filed with the SEC is 153, Booth Avenue, Englewood, Bergen County, New Jersey, 07631, United States.
Insiders trading at Rafael Inc
Over the last 7 years, insiders at Rafael Inc have traded over $423,229 worth of Rafael Inc stock and bought 3,338,367 units worth $11,056,239 . The most active insiders traders include Howard S Jonas, Mark Anthony Mc Camish a Plus, Llc I9. On average, Rafael Inc executives and independent directors trade stock every 87 days with the average trade being worth of $1,371,943. The most recent stock trade was executed by Howard S Jonas on 5 August 2022, trading 112,561 units of RFL stock currently worth $211,615.
What does Rafael Inc do?
we are a wholly owned subsidiary of rafael holdings focused on pipeline development
What does Rafael Inc's logo look like?
Complete history of Plus I9 stock trades at Rafael Inc
Rafael Inc executives and stock owners
Rafael Inc executives and other stock owners filed with the SEC include:
-
Menachem Ash,
President, General Counsel -
William Conkling,
Chief Exec. Officer -
David Polinsky,
Chief Financial Officer -
Howard S. Jonas,
Founder & Chairman -
David A. Polinsky Esq.,
Chief of Staff -
Howard Jonas,
Chairman of the Board, Chief Executive Officer -
Michael Weiss,
Independent Director -
Boris Pasche,
Independent Director -
Stephen Greenberg,
Lead Independent Director -
Joyce J. Mason Esq.,
Corp. Sec. -
Dr. Rick Ewing,
Head of Drug Discovery -
Gus Kodersha,
Chief Technical Operations Officer -
Barbara A. Ryan,
Investor Relations Officer -
Patrick Fabbio M.B.A.,
CFO & Pres -
Mary Margaret Huizinga,
Chief Devel. & Medical Officer -
John Goldberg,
CHIEF MEDICAL OFFICER -
William Conkling,
Chief Executive Officer -
Corp Idt,
10% owner -
Joyce J Mason,
-
Ashok D Marin,
Chief Legal Officer -
Mark Anthony Mc Camish,
Director -
Shannon Thyme Klinger,
Director -
Patrick Fabbio,
CFO & President -
Ameet Mallik,
Director -
Plus, Llc I9,
10% owner